Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia.

Dillon LW, Hayati S, Roloff GW, Tunc I, Pirooznia M, Mitrofanova A, Hourigan CS.

Haematologica. 2018 Aug 31. pii: haematol.2018.203133. doi: 10.3324/haematol.2018.203133. [Epub ahead of print]


NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.

Griffiths EA, Srivastava P, Matsuzaki J, Brumberger Z, Wang ES, Kocent J, Miller A, Roloff GW, Wong HY, Paluch BE, Lutgen-Dunckley LG, Martens BL, Odunsi K, Karpf AR, Hourigan CS, Nemeth MJ.

Clin Cancer Res. 2018 Mar 1;24(5):1019-1029. doi: 10.1158/1078-0432.CCR-17-1792. Epub 2017 Sep 25.


Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia.

Roloff GW, Lai C, Hourigan CS, Dillon LW.

J Clin Med. 2017 Sep 19;6(9). pii: E87. doi: 10.3390/jcm6090087. Review.


Colon cancer metastasis to the thyroid gland: report of a case with unique molecular profile.

Roloff GW, Yang Z, Wood LV, Neychev VK.

Clin Case Rep. 2016 Apr 22;4(6):549-53. doi: 10.1002/ccr3.497. eCollection 2016 Jun.


Tissue-of-origin-specific gene repositioning in breast and prostate cancer.

Meaburn KJ, Agunloye O, Devine M, Leshner M, Roloff GW, True LD, Misteli T.

Histochem Cell Biol. 2016 Apr;145(4):433-46. doi: 10.1007/s00418-015-1401-8. Epub 2016 Jan 20.


Locus-specific gene repositioning in prostate cancer.

Leshner M, Devine M, Roloff GW, True LD, Misteli T, Meaburn KJ.

Mol Biol Cell. 2016 Jan 15;27(2):236-46. doi: 10.1091/mbc.E15-05-0280. Epub 2015 Nov 12.

Supplemental Content

Loading ...
Support Center